← Back to Search

Monoclonal Antibodies

TEV-53275 Dose B for Asthma

Phase 2
Waitlist Available
Research Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 12 and 16
Awards & highlights

Study Summary

This study is evaluating whether a drug may help improve asthma symptoms for individuals with an eosinophilic phenotype.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 12 and 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 12 and 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Clinic-based Standardized Baseline-adjusted Morning Trough (Pre-bronchodilator) FEV1 at Week 12
Secondary outcome measures
Change From Baseline in Asthma Control Questionnaire (ACQ-6) Score at Weeks 12 and 16
Change From Baseline in Asthma Control Test (ACT) Score at Weeks 12 and 16
Change From Baseline in Clinic-based Standardized Baseline-adjusted Morning Trough (Pre-bronchodilator) FEV1 at Week 16
+20 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: TEV-53275 Dose BExperimental Treatment1 Intervention
Group II: TEV-53275 Dose AExperimental Treatment1 Intervention
Group III: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Teva Branded Pharmaceutical Products R&D, Inc.Lead Sponsor
251 Previous Clinical Trials
3,485,279 Total Patients Enrolled
63 Trials studying Asthma
2,616,114 Patients Enrolled for Asthma
Teva Medical Expert, MDStudy DirectorTeva Branded Pharmaceutical Products R&D, Inc.
93 Previous Clinical Trials
38,674 Total Patients Enrolled
22 Trials studying Asthma
12,543 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Nebraska
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study to Test if TEV-53275 is Effective in Relieving Asthma
2021. "A Study to Test if TEV-53275 is Effective in Relieving Asthma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04847674.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top